Diabetics and healthcare advocates rally on November 14, 2019--World Diabetes Day--in New York City as part of the Lower Drug Prices Now Campaign's National Day of Action. (Photo: Erik McGregor/LightRocket via Getty Images)
Nov 23, 2021
As a new survey published Tuesday showed overwhelming support among American voters for capping the cost of insulin at $35 per month, progressive U.S. lawmakers underscored what they insisted is the Senate's imperative to include a provision allowing Medicare to negotiate lower drug prices in its version of the Build Back Better budget reconciliation bill.
The Data for Progress poll found that 87% of all respondents--including 94% of self-described Democrats, 84% of Independents, and 82% of Republicans--"strongly" or "somewhat" favor the insulin price cap.
Writing for Data for Progress, Sen. Ron Wyden (D-Ore.) noted that the House version of the Build Back Better Act, which was passed last week, "will allow Medicare to negotiate the prices of certain pharmaceuticals, including insulin."
\u201cNEW POLL: An overwhelming majority of voters support capping insulin costs at $35 per month \u2014 a proposal included in the Build Back Better Act.\n\nThat includes Independents by a +76-point margin and Republicans by a +71-point margin.\u201d— Data for Progress (@Data for Progress) 1637687244
"It also creates a cap so that no one pays more than $35 per month for insulin," he continued. "Let me say that again: House Democrats just passed a cap on the price of insulin at $35 per month--and now it's time for the Senate to get it done."
"American families currently pay thousands of dollars a year for their insulin, far more than any other nation," said Wyden, "even though its estimated cost of manufacturing is just $2.28 to $6.34 per vial, the sticker price for a single vial of insulin is $300. That's hundreds of dollars a month out of the pockets of millions of families in Oregon and families across the country for a drug that's been around for decades due to the uncontrolled greed of the pharmaceutical industry."
"The effects are disastrous," he added. "For instance, one quarter of Americans with Type 1 diabetes ration their insulin due to its exorbitant costs. By capping the price of insulin at $35 per month, the Build Back Better Act can help millions of Americans get the insulin they need at a price they can afford."
\u201cThe Build Back Better Act will cap out-of-pocket insulin costs at $35 per month. \n\nThinking of Alec Smith, a Minnesota restaurant manager who tragically passed away because he couldn\u2019t afford the cost of his insulin.\n\nThis insulin cap is for him and so many others.\u201d— Rep. Ilhan Omar (@Rep. Ilhan Omar) 1637681458
Senate Budget Committee Chair Bernie Sanders (I-Vt.) tweeted Tuesday that "insulin should not cost 10 times as much in the United States as it does in Canada. Period."
An Unconstitutional Rampage
Trump and Musk are on an unconstitutional rampage, aiming for virtually every corner of the federal government. These two right-wing billionaires are targeting nurses, scientists, teachers, daycare providers, judges, veterans, air traffic controllers, and nuclear safety inspectors. No one is safe. The food stamps program, Social Security, Medicare, and Medicaid are next. It’s an unprecedented disaster and a five-alarm fire, but there will be a reckoning. The people did not vote for this. The American people do not want this dystopian hellscape that hides behind claims of “efficiency.” Still, in reality, it is all a giveaway to corporate interests and the libertarian dreams of far-right oligarchs like Musk. Common Dreams is playing a vital role by reporting day and night on this orgy of corruption and greed, as well as what everyday people can do to organize and fight back. As a people-powered nonprofit news outlet, we cover issues the corporate media never will, but we can only continue with our readers’ support. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
healthcarerights & justiceus congressbig pharmamedicaredata for progressbernie sandersilhan omarron wyden
As a new survey published Tuesday showed overwhelming support among American voters for capping the cost of insulin at $35 per month, progressive U.S. lawmakers underscored what they insisted is the Senate's imperative to include a provision allowing Medicare to negotiate lower drug prices in its version of the Build Back Better budget reconciliation bill.
The Data for Progress poll found that 87% of all respondents--including 94% of self-described Democrats, 84% of Independents, and 82% of Republicans--"strongly" or "somewhat" favor the insulin price cap.
Writing for Data for Progress, Sen. Ron Wyden (D-Ore.) noted that the House version of the Build Back Better Act, which was passed last week, "will allow Medicare to negotiate the prices of certain pharmaceuticals, including insulin."
\u201cNEW POLL: An overwhelming majority of voters support capping insulin costs at $35 per month \u2014 a proposal included in the Build Back Better Act.\n\nThat includes Independents by a +76-point margin and Republicans by a +71-point margin.\u201d— Data for Progress (@Data for Progress) 1637687244
"It also creates a cap so that no one pays more than $35 per month for insulin," he continued. "Let me say that again: House Democrats just passed a cap on the price of insulin at $35 per month--and now it's time for the Senate to get it done."
"American families currently pay thousands of dollars a year for their insulin, far more than any other nation," said Wyden, "even though its estimated cost of manufacturing is just $2.28 to $6.34 per vial, the sticker price for a single vial of insulin is $300. That's hundreds of dollars a month out of the pockets of millions of families in Oregon and families across the country for a drug that's been around for decades due to the uncontrolled greed of the pharmaceutical industry."
"The effects are disastrous," he added. "For instance, one quarter of Americans with Type 1 diabetes ration their insulin due to its exorbitant costs. By capping the price of insulin at $35 per month, the Build Back Better Act can help millions of Americans get the insulin they need at a price they can afford."
\u201cThe Build Back Better Act will cap out-of-pocket insulin costs at $35 per month. \n\nThinking of Alec Smith, a Minnesota restaurant manager who tragically passed away because he couldn\u2019t afford the cost of his insulin.\n\nThis insulin cap is for him and so many others.\u201d— Rep. Ilhan Omar (@Rep. Ilhan Omar) 1637681458
Senate Budget Committee Chair Bernie Sanders (I-Vt.) tweeted Tuesday that "insulin should not cost 10 times as much in the United States as it does in Canada. Period."
From Your Site Articles
As a new survey published Tuesday showed overwhelming support among American voters for capping the cost of insulin at $35 per month, progressive U.S. lawmakers underscored what they insisted is the Senate's imperative to include a provision allowing Medicare to negotiate lower drug prices in its version of the Build Back Better budget reconciliation bill.
The Data for Progress poll found that 87% of all respondents--including 94% of self-described Democrats, 84% of Independents, and 82% of Republicans--"strongly" or "somewhat" favor the insulin price cap.
Writing for Data for Progress, Sen. Ron Wyden (D-Ore.) noted that the House version of the Build Back Better Act, which was passed last week, "will allow Medicare to negotiate the prices of certain pharmaceuticals, including insulin."
\u201cNEW POLL: An overwhelming majority of voters support capping insulin costs at $35 per month \u2014 a proposal included in the Build Back Better Act.\n\nThat includes Independents by a +76-point margin and Republicans by a +71-point margin.\u201d— Data for Progress (@Data for Progress) 1637687244
"It also creates a cap so that no one pays more than $35 per month for insulin," he continued. "Let me say that again: House Democrats just passed a cap on the price of insulin at $35 per month--and now it's time for the Senate to get it done."
"American families currently pay thousands of dollars a year for their insulin, far more than any other nation," said Wyden, "even though its estimated cost of manufacturing is just $2.28 to $6.34 per vial, the sticker price for a single vial of insulin is $300. That's hundreds of dollars a month out of the pockets of millions of families in Oregon and families across the country for a drug that's been around for decades due to the uncontrolled greed of the pharmaceutical industry."
"The effects are disastrous," he added. "For instance, one quarter of Americans with Type 1 diabetes ration their insulin due to its exorbitant costs. By capping the price of insulin at $35 per month, the Build Back Better Act can help millions of Americans get the insulin they need at a price they can afford."
\u201cThe Build Back Better Act will cap out-of-pocket insulin costs at $35 per month. \n\nThinking of Alec Smith, a Minnesota restaurant manager who tragically passed away because he couldn\u2019t afford the cost of his insulin.\n\nThis insulin cap is for him and so many others.\u201d— Rep. Ilhan Omar (@Rep. Ilhan Omar) 1637681458
Senate Budget Committee Chair Bernie Sanders (I-Vt.) tweeted Tuesday that "insulin should not cost 10 times as much in the United States as it does in Canada. Period."
From Your Site Articles
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.